Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1951 1
1961 1
1969 1
1974 1
1975 2
1976 3
1978 2
1979 2
1981 4
1982 2
1983 5
1984 6
1985 2
1986 4
1987 7
1988 6
1989 7
1990 5
1991 2
1992 8
1993 4
1994 3
1995 3
1996 7
1997 5
1998 11
1999 13
2000 7
2001 5
2002 8
2003 14
2004 8
2005 13
2006 19
2007 15
2008 27
2009 16
2010 22
2011 20
2012 15
2013 31
2014 25
2015 22
2016 31
2017 30
2018 31
2019 34
2020 47
2021 53
2022 42
2023 43
2024 39

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

639 results

Results by year

Filters applied: . Clear all
Page 1
Pembrolizumab plus chemotherapy versus placebo plus chemotherapy for previously untreated locally recurrent inoperable or metastatic triple-negative breast cancer (KEYNOTE-355): a randomised, placebo-controlled, double-blind, phase 3 clinical trial.
Cortes J, Cescon DW, Rugo HS, Nowecki Z, Im SA, Yusof MM, Gallardo C, Lipatov O, Barrios CH, Holgado E, Iwata H, Masuda N, Otero MT, Gokmen E, Loi S, Guo Z, Zhao J, Aktan G, Karantza V, Schmid P; KEYNOTE-355 Investigators. Cortes J, et al. Among authors: otero mt. Lancet. 2020 Dec 5;396(10265):1817-1828. doi: 10.1016/S0140-6736(20)32531-9. Lancet. 2020. PMID: 33278935 Clinical Trial.
Inflammation in osteoarthritis.
Goldring MB, Otero M. Goldring MB, et al. Among authors: otero m. Curr Opin Rheumatol. 2011 Sep;23(5):471-8. doi: 10.1097/BOR.0b013e328349c2b1. Curr Opin Rheumatol. 2011. PMID: 21788902 Free PMC article. Review.
Automated multi-scale computational pathotyping (AMSCP) of inflamed synovial tissue.
Bell RD, Brendel M, Konnaris MA, Xiang J, Otero M, Fontana MA, Bai Z; Accelerating Medicines Partnership Rheumatoid Arthritis and Systemic Lupus Erythematosus (AMP RA/SLE) Consortium; Krenitsky DM, Meednu N, Rangel-Moreno J, Scheel-Toellner D, Carr H, Nayar S, McMurray J, DiCarlo E, Anolik JH, Donlin LT, Orange DE, Kenney HM, Schwarz EM, Filer A, Ivashkiv LB, Wang F. Bell RD, et al. Among authors: otero m. Nat Commun. 2024 Aug 29;15(1):7503. doi: 10.1038/s41467-024-51012-6. Nat Commun. 2024. PMID: 39209814 Free PMC article.
Modeling dengue outbreaks.
Otero M, Barmak DH, Dorso CO, Solari HG, Natiello MA. Otero M, et al. Math Biosci. 2011 Aug;232(2):87-95. doi: 10.1016/j.mbs.2011.04.006. Epub 2011 May 5. Math Biosci. 2011. PMID: 21570411
Smart Adsorbents for Aquatic Environmental Remediation.
Nazarzadeh Zare E, Mudhoo A, Ali Khan M, Otero M, Bundhoo ZMA, Patel M, Srivastava A, Navarathna C, Mlsna T, Mohan D, Pittman CU Jr, Makvandi P, Sillanpää M. Nazarzadeh Zare E, et al. Among authors: otero m. Small. 2021 Aug;17(34):e2007840. doi: 10.1002/smll.202007840. Epub 2021 Apr 25. Small. 2021. PMID: 33899324 Review.
Biological properties of exopolysaccharides produced by Bacillus spp.
Díaz-Cornejo S, Otero MC, Banerjee A, Gordillo-Fuenzalida F. Díaz-Cornejo S, et al. Among authors: otero mc. Microbiol Res. 2023 Mar;268:127276. doi: 10.1016/j.micres.2022.127276. Epub 2022 Dec 5. Microbiol Res. 2023. PMID: 36525789 Free article. Review.
Blocking IL-6 signaling prevents astrocyte-induced neurodegeneration in an iPSC-based model of Parkinson's disease.
Pons-Espinal M, Blasco-Agell L, Fernandez-Carasa I, Andrés-Benito P, di Domenico A, Richaud-Patin Y, Baruffi V, Marruecos L, Espinosa L, Garrido A, Tolosa E, Edel MJ, Otero MJ, Mosquera JL, Ferrer I, Raya A, Consiglio A. Pons-Espinal M, et al. Among authors: otero mj. JCI Insight. 2024 Feb 8;9(3):e163359. doi: 10.1172/jci.insight.163359. JCI Insight. 2024. PMID: 38329129 Free PMC article.
Switching to Interleukin-23 Inhibitors After Ineffectiveness of Ustekinumab: Evaluating Real-World Outcomes in Psoriasis Treatment.
Thomas SE, Seyger MMB, Mangnus JE, Otero ME, Gostynski AH, Njoo MD, Ossenkoppele PM, Haeck IM, Hendricksen-Roelofzen JHJ, Körver JEM, Dodemont SRP, Tupker RA, Berends MAM, Weppner-Parren LMJT, Keijsers RRMC, Oostveen AM, Peters B, Mommers R, van Doorn MBA, Tjioe M, Veldkamp WR, Kuijpers ALA, Kleinpenning MM, de Jong EMGJ, van den Reek JMPA. Thomas SE, et al. Among authors: otero me. Am J Clin Dermatol. 2024 Jul;25(4):685-688. doi: 10.1007/s40257-024-00868-x. Epub 2024 May 27. Am J Clin Dermatol. 2024. PMID: 38802618 No abstract available.
Health-related quality of life with pembrolizumab plus chemotherapy vs placebo plus chemotherapy for advanced triple-negative breast cancer: KEYNOTE-355.
Cescon DW, Schmid P, Rugo HS, Im SA, Md Yusof M, Gallardo C, Lipatov O, Barrios CH, Perez-Garcia J, Iwata H, Masuda N, Otero MT, Gokmen E, Loi S, Haiderali A, Zhou X, Guo Z, Nguyen AM, Cortes J. Cescon DW, et al. Among authors: otero mt. J Natl Cancer Inst. 2024 May 8;116(5):717-727. doi: 10.1093/jnci/djad240. J Natl Cancer Inst. 2024. PMID: 38070159 Clinical Trial.
639 results